Table 1 Preoperative demographical and clinical data for CSLH, MIDLH, and RALH groups
Variables | CSLH (n = 64) | MIDLH (n = 42) | RALH (n = 32) | p value |
|---|---|---|---|---|
Age (years) | 61.6 ± 10.6 | 60.5 ± 10.8 | 61.5 ± 10.5 | 0.873 |
Male gender (%) | 52 (81.2%) | 33 (78.6%) | 26 (81.2%) | 0.937 |
Height (cm) | 163.4 ± 6.9 | 163.4 ± 7.4 | 164.6 ± 7.4 | 0.669 |
Weight (kg) | 68 ± 10.3 | 65 ± 10.9 | 68.3 ± 10.1 | 0.276 |
BMI (Kg/m2) | 25.4 ± 3.0 | 23.8 ± 3.0 | 24.6 ± 2.7 | 0.022 |
Hx of hypertension (%) | 49 (76.6%) | 21 (50%) | 24 (75%) | 0.010 |
Hx of DM (%) | 23 (35.9%) | 13 (30.9%) | 9 (28.1%) | 0.721 |
Hx of hyperlipidemia (%) | 9 (14.1%) | 5 (11.9%) | 5 (15.6%) | 0.898 |
Hx of smoking (%) | 29 (45.3%) | 15 (35.7%) | 12 (37.5%) | 0.573 |
LVEF (%) | 63.1 ± 8.5 | 63 ± 9.2 | 67.2 ± 7.7 | 0.060 |
LVEDD (mm) | 48.0 ± 5.6 | 46.9 ± 5.3 | 47.8 ± 5.1 | 0.573 |
Hx of renal impairment (%) | 5 (7.8%) | 3 (7.1%) | 0 (0%) | 0.279 |
Hx of COPD (%) | 0 (%) | 2 (4.8%) | 0 (0%) | 0.099 |
Hx of CVD (%) | 8 (12.5%) | 8 (19%) | 5 (15.6%) | 0.660 |
Hx of PVD (%) | 4 (6.2%) | 3 (7.1%) | 1 (3.1%) | 0.752 |
HCR (%) | 8 PCI (12.5) | 10 (23.8%) | 6 (18.7%) | NA |